Harnessing Small Molecules for Revealing Vulnerabilities in Circulating Tumor Cells.
RNA-seq (gene expression) · human · 42 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 42 samples: 42 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Novel Cell Cycle Inhibitors Decrease Primary and Metastatic Breast Cancer Growth In VivoCancers · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE251771_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1055444 and SRA study SRP479404. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 42 sample titles: 42 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7987540 Control_1_2h
- GSM7987541 Control_1_6h
- GSM7987542 Control_2_2h
- GSM7987543 Control_2_6h
- GSM7987544 Control_3_2h
- GSM7987545 Control_3_6h
- GSM7987546 DF-06_1_2h
- GSM7987547 DF-06_1_6h
- GSM7987548 DF-06_2_2h
- GSM7987549 DF-06_2_6h
- GSM7987550 DF-06_3_2h
- GSM7987551 DF-06_3_6h
- GSM7987552 IIIM-368_1_2h
- GSM7987553 IIIM-368_1_6h
- GSM7987554 IIIM-368_2_2h
- GSM7987555 IIIM-368_2_6h
- GSM7987556 IIIM-368_3_2h
- GSM7987557 IIIM-368_3_6h
- GSM7987558 PLS-69_1_2h
- GSM7987559 PLS-69_1_6h
- GSM7987560 PLS-69_2_2h
- GSM7987561 PLS-69_2_6h
- GSM7987562 PLS-69_3_2h
- GSM7987563 PLS-69_3_6h
- GSM7987564 US-463_1_2h
- GSM7987565 US-463_1_6h
- GSM7987566 US-463_2_2h
- GSM7987567 US-463_2_6h
- GSM7987568 US-463_3_2h
- GSM7987569 US-463_3_6h
- GSM7987570 US-464_1_2h
- GSM7987571 US-464_1_6h
- GSM7987572 US-464_2_2h
- GSM7987573 US-464_2_6h
- GSM7987574 US-464_3_2h
- GSM7987575 US-464_3_6h
- GSM7987576 US-748_1_2h
- GSM7987577 US-748_1_6h
- GSM7987578 US-748_2_2h
- GSM7987579 US-748_2_6h
+ 2 more — browse all 42 samples with per-sample file links →
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing
- GSE311200 Comprehensive analysis of the correlation between circulating biomarkers and tumor-immune microenvironment in advanced or recurrence non-small cell lung cancer in various treatment options, i.e., immunotherapy, EGFR TKI, and chemotherapy 41 samples shares circulating, small
- GSE330903 Depleting prion protein using splice-switching small molecules 31 samples shares molecules, small
- GSE273816 Redirecting the pioneering function of FOXA1 with covalent small molecules 12 samples shares molecules, small
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.